WuXi, Biologics

WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates

Veröffentlicht: 07.08.2025 um 18:06 Uhr, prnewswire.co.uk

WuXi Biologics China

View original content:https://www.prnewswire.co.uk/news-releases/wuxi-biologics-announces-research-service-agreement-with-biontech-on-discovering-investigational-monoclonal-antibodies-for-developing-next-generation-therapeutic-product-candidates-302031587.html

en | CA7609751028 | WUXI | boerse | 67950578 |